antazoline has been researched along with procainamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Downar, E; Waxman, MB | 1 |
BAIRD, WM; CLIFFORD, ME; REYNOLDS, EW | 1 |
1 trial(s) available for antazoline and procainamide
Article | Year |
---|---|
Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report.
Topics: Adolescent; Adult; Aged; Antazoline; Arrhythmias, Cardiac; Chronic Disease; Clinical Trials as Topic; Digoxin; Drug Evaluation; Female; Humans; Imidazoles; Male; Middle Aged; Procainamide; Propranolol; Quinidine; Recurrence | 1975 |
2 other study(ies) available for antazoline and procainamide
Article | Year |
---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
A CLINICAL TRIAL OF ANTAZOLINE IN THE TREATMENT OF ARRHYTHMIAS.
Topics: Antazoline; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Complexes, Premature; Coronary Disease; Drug Therapy; Electrocardiography; Heart Diseases; Histamine H1 Antagonists; Humans; Procainamide; Quinidine; Rheumatic Heart Disease; Tachycardia; Tachycardia, Paroxysmal; Toxicology; Ventricular Fibrillation | 1964 |